Friday, July 31, 2026

Younger Women With Stomach Cancer Face Worse Outcomes Than Men, Study Finds

Women under 50 with stomach cancer have worse outcomes than men, highlighting the need for proactive screening and management.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Discover the New Turbineu Double Action Aerosol: The Ultimate Solution for Athlete’s Foot in 2026

Dong-A Pharmaceutical has launched 'Turbinew Double Action Aerosol', an easy-to-use spray treatment for athlete's foot.

Tag: Rigakem Bio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

IKS04: The New ADC Candidate for GI Cancer Approved by FDA – What You Need to Know

LigaChemBio's ADC platform technology enters U.S. clinical trials for gastrointestinal cancer, showcasing its competitive edge in the field.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.